ES2040391T3 - Procedimiento para producir composiciones farmaceuticas para la aplicacion transdermica de heparina. - Google Patents

Procedimiento para producir composiciones farmaceuticas para la aplicacion transdermica de heparina.

Info

Publication number
ES2040391T3
ES2040391T3 ES89102823T ES89102823T ES2040391T3 ES 2040391 T3 ES2040391 T3 ES 2040391T3 ES 89102823 T ES89102823 T ES 89102823T ES 89102823 T ES89102823 T ES 89102823T ES 2040391 T3 ES2040391 T3 ES 2040391T3
Authority
ES
Spain
Prior art keywords
heparin
procedure
pharmaceutical compositions
produce pharmaceutical
transdermic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89102823T
Other languages
English (en)
Inventor
G Prof Dr Med Stuttgen
Klaus Gehlhaar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schur Pharmazeutika & Co GmbH
Original Assignee
Schur Pharmazeutika & Co GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schur Pharmazeutika & Co GmbH filed Critical Schur Pharmazeutika & Co GmbH
Application granted granted Critical
Publication of ES2040391T3 publication Critical patent/ES2040391T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL PRESENTE INVENTO ESTA RELACIONADO A COMPOSICIONES FARMACEUTICAS PARA LA APLICACION TRANSDERMAL DE HEPARIN.
ES89102823T 1988-02-22 1989-02-18 Procedimiento para producir composiciones farmaceuticas para la aplicacion transdermica de heparina. Expired - Lifetime ES2040391T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3805523A DE3805523A1 (de) 1988-02-22 1988-02-22 Pharmazeutische praeparate zur transdermalen applikation von heparin

Publications (1)

Publication Number Publication Date
ES2040391T3 true ES2040391T3 (es) 1996-07-16

Family

ID=6347919

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89102823T Expired - Lifetime ES2040391T3 (es) 1988-02-22 1989-02-18 Procedimiento para producir composiciones farmaceuticas para la aplicacion transdermica de heparina.

Country Status (8)

Country Link
EP (1) EP0331948B1 (es)
AT (1) ATE71529T1 (es)
DE (2) DE3805523A1 (es)
DK (1) DK79289A (es)
ES (1) ES2040391T3 (es)
GR (1) GR3003666T3 (es)
IE (1) IE61287B1 (es)
PT (1) PT89781B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
ITMI20042505A1 (it) * 2004-12-24 2005-03-24 Oro Consulting S R L Sostanza emulsionante e-o tensioattiva ad attivita' battericida per la preparazione di emulsioni e di tensidi per uso dermofarmaceutico e cosmetico emulsioni e tensidi preparati con questa sostanzaa prodotto dermofarmaceutico e prodotto cosmetico ott

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729989A (en) * 1985-06-28 1988-03-08 Merck & Co., Inc. Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
US4692441A (en) * 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
JPH0753671B2 (ja) * 1985-12-26 1995-06-07 積水化学工業株式会社 経皮・経粘膜製剤

Also Published As

Publication number Publication date
IE61287B1 (en) 1994-10-19
IE890537L (en) 1989-08-22
GR3003666T3 (es) 1993-03-16
PT89781A (pt) 1989-10-04
DE68900693D1 (de) 1992-02-27
DE3805523A1 (de) 1989-10-05
PT89781B (pt) 1994-05-31
EP0331948A3 (en) 1990-02-07
ATE71529T1 (de) 1992-02-15
DK79289A (da) 1989-08-23
DK79289D0 (da) 1989-02-21
EP0331948A2 (en) 1989-09-13
EP0331948B1 (en) 1992-01-15

Similar Documents

Publication Publication Date Title
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
IT1190349B (it) Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
ATE48093T1 (de) O/w emulsion zusammensetzung.
BR9815418A (pt) Composição farmacêutica ou cosmética tópica, composição farmacêutica, alimentar ou cosmética e utilização de pelo menos um dos agnim
SE8900828D0 (sv) Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma
ATE45091T1 (de) Pharmazeutische zubereitung mit speziellen 1,2diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich.
PT90308A (pt) Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa
PT83624B (pt) Processo para a preparacao de composicoes farmaceuticas contendo analogos da prostaglandina
ES2040391T3 (es) Procedimiento para producir composiciones farmaceuticas para la aplicacion transdermica de heparina.
ES2053101T3 (es) Compuesto detergente para la piel.
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
KR890701098A (ko) 히드로퀴논 및 코지산을 함유하는 제약 또는 화장제 조성물
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
EP0335446A3 (en) Agents for treating neoplasms
ES543797A0 (es) Procedimiento de preparacion de nuevos derivados benzohi- drilpiperacinos y sus sales de adicion acidas
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.
KR930700496A (ko) 약물학적 활성을 갖는 s-(2-테노일)-티오젖산 유도체
ES8500620A1 (es) Procedimiento para la preparacion de derivados e-homo-eburnanos racemicos u opticamente activos y de sus sales de adicion acidas.
IT1233426B (it) Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 331948

Country of ref document: ES

FG2A Definitive protection

Ref document number: 0331948

Country of ref document: ES